Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 19 studies | 50% ± 20% | |
| astrocyte | 17 studies | 45% ± 19% | |
| fibroblast | 14 studies | 31% ± 16% | |
| type I pneumocyte | 10 studies | 35% ± 14% | |
| type II pneumocyte | 10 studies | 37% ± 15% | |
| epithelial cell | 9 studies | 38% ± 16% | |
| adipocyte | 9 studies | 33% ± 11% | |
| secretory cell | 8 studies | 49% ± 26% | |
| respiratory goblet cell | 7 studies | 67% ± 20% | |
| club cell | 6 studies | 60% ± 16% | |
| goblet cell | 6 studies | 33% ± 16% | |
| ciliated cell | 6 studies | 36% ± 18% | |
| retinal pigment epithelial cell | 5 studies | 34% ± 10% | |
| Mueller cell | 5 studies | 62% ± 14% | |
| deuterosomal cell | 4 studies | 46% ± 14% | |
| duct epithelial cell | 4 studies | 30% ± 14% | |
| adventitial cell | 4 studies | 24% ± 6% | |
| connective tissue cell | 4 studies | 33% ± 14% | |
| squamous epithelial cell | 3 studies | 69% ± 11% | |
| podocyte | 3 studies | 41% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 97% | 7394.02 | 563 / 578 | 91% | 140.52 | 1050 / 1155 |
| prostate | 97% | 6011.26 | 237 / 245 | 90% | 237.39 | 452 / 502 |
| pancreas | 81% | 7474.98 | 265 / 328 | 93% | 203.39 | 165 / 178 |
| thymus | 100% | 8649.62 | 650 / 653 | 73% | 61.05 | 441 / 605 |
| stomach | 92% | 4194.82 | 329 / 359 | 74% | 48.26 | 212 / 286 |
| brain | 76% | 5150.10 | 2010 / 2642 | 89% | 133.36 | 630 / 705 |
| intestine | 80% | 4702.06 | 775 / 966 | 85% | 63.96 | 448 / 527 |
| esophagus | 67% | 2413.82 | 961 / 1445 | 86% | 73.90 | 157 / 183 |
| bladder | 86% | 8097.05 | 18 / 21 | 63% | 84.73 | 318 / 504 |
| breast | 100% | 9231.26 | 458 / 459 | 47% | 27.81 | 525 / 1118 |
| uterus | 69% | 3521.46 | 118 / 170 | 72% | 159.30 | 330 / 459 |
| adrenal gland | 79% | 2420.15 | 205 / 258 | 43% | 27.06 | 100 / 230 |
| ovary | 96% | 14421.88 | 172 / 180 | 18% | 7.50 | 77 / 430 |
| skin | 99% | 7054.55 | 1792 / 1809 | 7% | 3.08 | 35 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.26 | 1 / 1 |
| adipose | 100% | 12517.73 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 82% | 3325.18 | 1089 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 88.36 | 36 / 45 |
| kidney | 58% | 1464.92 | 52 / 89 | 10% | 6.35 | 87 / 901 |
| heart | 51% | 1202.98 | 443 / 861 | 0% | 0 | 0 / 0 |
| spleen | 20% | 526.90 | 49 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 3.84 | 3 / 29 |
| liver | 3% | 58.24 | 7 / 226 | 7% | 4.01 | 28 / 406 |
| muscle | 8% | 159.32 | 68 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 1.28 | 2 / 80 |
| peripheral blood | 0% | 4.51 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_0010641 | Biological process | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO_0045766 | Biological process | positive regulation of angiogenesis |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0016485 | Biological process | protein processing |
| GO_0002541 | Biological process | activation of plasma proteins involved in acute inflammatory response |
| GO_0007596 | Biological process | blood coagulation |
| GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0032757 | Biological process | positive regulation of interleukin-8 production |
| GO_0050927 | Biological process | positive regulation of positive chemotaxis |
| GO_0032008 | Biological process | positive regulation of TOR signaling |
| GO_0002543 | Biological process | activation of blood coagulation via clotting cascade |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_1905286 | Cellular component | serine-type peptidase complex |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0009986 | Cellular component | cell surface |
| GO_0005543 | Molecular function | phospholipid binding |
| GO_0002020 | Molecular function | protease binding |
| GO_0004896 | Molecular function | cytokine receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | F3 |
| Protein name | Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142) |
| Synonyms | |
| Description | FUNCTION: Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade. . |
| Accessions | P13726 ENST00000334047.12 [P13726-1] ENST00000370207.4 [P13726-2] |